South Korea’s preferential drug pricing system can boost innovation in pharma research, says GlobalData

South Korea has recently decided to provide practical support to innovative pharmaceutical companies by revising the existing health insurance benefits system. The new system of preferential drug pricing, if designed effectively, can boost innovation in the country’s pharmaceutical research, says GlobalData, a leading data and analytics company.

Read the source article at Home – GlobalData
2021-09-08 03:59:04